Skip to main navigation Skip to search Skip to main content

The cost-effectiveness of using pneumococcal conjugate vaccine (PCV13) versus pneumococcal polysaccharide vaccine (PPSV23), in South African adults

  • Charles Feldman
  • , Sipho K. Dlamini
  • , Shabir A. Madhi
  • , Susan Meiring
  • , Anne Von Gottberg
  • , Janetta C. De Beer
  • , Margreet De Necker
  • , Marthinus P. Stander
  • University of the Witwatersrand
  • University of Cape Town
  • National Health Laboratory Services
  • TCD Outcomes Research (Pty) Ltd

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The cost-effectiveness of using pneumococcal conjugate vaccine (PCV13) versus pneumococcal polysaccharide vaccine (PPSV23), in South African adults'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases

Immunology and Microbiology

Medicine and Dentistry